Introduction
Eosinophilic esophagitis (EoE) represents an emerging gastrointestinal disorder characterized by symptoms of esophageal dysfunction, including dysphagia and food impaction, along with marked esophageal eosinophilia in mucosal biopsies, both of which persist after treatment for acid gastroesophageal reflux [1] . First defined 20 years ago as a distinctive clinico-pathological syndrome [2] , EoE currently represents an emerging chronic disease that usually persists from childhood into adulthood [3•, 4] , with an estimated prevalence of 43-56 cases/100,000 inhabitants in both America and Europe, affecting both children and adults [5] [6] [7] [8] .
EoE has been related to allergies since its first descriptions. In fact, pediatric and adult patients commonly present a family or personal allergic background, including asthma, rhinitis, conjunctivitis, or eczema with variable frequency [1] . Moreover, peripheral eosinophilia is present in 50 % of patients, with three out of four exhibiting elevated serum IgE levels [9] . Food and aeroallergen sensitization are also common, as determined by means of positive skin prick tests (SPTs) in patients of all ages [10] [11] [12] . However, the definitive definition of EoE as a characteristic manifestation of food allergy only came after disease remission was achieved by feeding a series of pediatric patients exclusively with an amino acid-based elemental formula [13] . In this groundbreaking study, the disease recurred in all cases once patients resumed a normal diet, demonstrating unequivocally for the first time that food allergy plays a causal role in chronic esophagitis, while simultaneously establishing a gold standard for comparing subsequent therapies.
However, despite the great number of studies carried out on the disease over the past 20 years, management of EoE remains controversial. Current treatments include the use of swallowed steroids with a topical effect, various dietary modifications, and endoscopic dilation. Even more recently, several monoclonal antibodies have been assayed [14] . With all this, a commonly accepted algorithm for treating patients is still lacking, mostly due to limited information regarding the long-term effects of different therapies in modifying the natural history of the disease and its associated subepithelial fibrosis [14, 15•, 16•] . As a result, there is a wide variability in both the standard of care for EoE patients and the adherence to proposed international guidelines in clinical practice [6, 17•] .
An increasing body of knowledge has recently renewed interest in the dietary management of EoE as a drug-free alternative to topical steroids, which still constitute the most widely utilized medical treatment for EoE in patients of all ages. This article aims to review all available dietary approaches for the management of EoE, along with the advantages and limitations of each, in order to provide practical advice for the successful management of EoE through diet.
Treatment
& The natural history of EoE is starting to become more clearly defined, mainly through longitudinal studies focused on determining the evolution of the untreated disease. We know that, in the absence of treatment, EoE tends to persist over time, with chronic symptoms and inflammation significantly affecting health-related quality of life (QoL) [3• ], but usually with no impact on the nutritional state of the patient [18] . Characteristic endoscopic features in children include acute inflammation, especially mucosal edema, along with whitish exudates and linear furrows [19] ; adult patients additionally present with fibrotic changes, such as rings and strictures [20] . However, no malignant potential has been associated with EoE until now [18] . 
Summary of available alternatives to dietary therapy for EoE
& Pharmacological treatment for EoE patients has mainly comprised the use of several anti-inflammatory drugs used in other allergic disorders. The first reported cases of EoE were effectively managed with systemic steroids, which were later replaced by topical steroids after these were shown to have a similar effectiveness with a lower rate of side effects. First used in pediatric patients [22] , topicallyadministered swallowed fluticasone propionate (FP) has been shown to be highly effective in children [23] , significantly superior to a placebo [24] and comparable to oral prednisone [25] (1b, grade A). Similar results have been documented in adults [26] . Viscous budesonide has also emerged as an alternative treatment for both children [27] and adults with EoE [28] , having been proven safe and effective (1b, grade A). Ciclesonide has also recently been added to the pharmacological armory for treating EoE [29] . However, given the chronic nature of EoE, sustained treatment with steroids or repeated courses must be considered, even after achieving disease remission. Finally, azathioprine/ 6 mercaptopurine was found to be effective in causing the remission of symptoms and eosinophilic infiltration for periods of 3-8 years in adults with steroid-dependent EoE and eosinophilic gastroenteritis with esophageal involvement [30] . [33] , nor did the anti-IgE omalizumab lead to clinical improvement in children [34] . However, when the anti-IL-5 monoclo-nal antibodies mepolizumab and reslizumab were analyzed in randomized, controlled trials in both adult [35] and pediatric [36, 37] patients, tissue eosinophils were significantly reduced. Unfortunately, clinical improvement was minimal. (1b, grade A). & Despite the fact that EoE is defined as the persistence of eosinophilic inflammation after acid suppression, proton pump inhibitors (PPIs) have been used successfully as a sole therapy for EoE patients [38, 39] . The anti-inflammatory properties of PPIs were recently demonstrated in vitro after they were able to reduce the gene expression of eotaxin-3 (a key chemo-attractant involved in the pathophysiology of the disease) in esophageal cell cultures from EoE patients [40] . Until a clearer elucidation of the real significance of PPI-responsive EoE is developed, consensus guidelines currently consider this disease to be a specific manifestation of gastroesophageal reflux disease [1] . & Endoscopic dilation, a mechanical procedure with no effect on the underlying inflammatory process, seems to result in at least a shortterm improvement of symptoms in the majority of patients, according to a recent meta-analysis [41] . It has mostly been used in adult EoE patients, who often present esophageal stenosis with a reduction of esophageal caliber. When performed by an experienced specialist, esophageal dilation is a safe procedure [41] . However, various risk factors for complications have been identified, including a long evolution of dysphagia, high eosinophil density, young patient age, repeated procedures, and luminal narrowing in the upper and middle esophageal thirds [42, 43] .
Dietary approaches for EoE Elemental diet in EoE
& Since 1995, after an initial report showed that feeding 10 children exclusively with an amino acid-based elemental formula led to symptom relief and histological normalization of EoE [13] , several studies have reproduced these findings in pediatric series [44, 45••, 46••] . In fact, results show that more than 90 % of patients rapidly reach peak eosinophil counts G15/hpf, with symptomatic improvement in 996 % of cases (4, grade C). Moreover, subsequent controlled re-introduction of solid foods results in recurrence of gastrointestinal symptoms specific to individual "trigger" foods. & The first report regarding the use of elemental diet to treat adult EoE has been published only very recently [47••] . A series of 29 patients were prospectively recruited and told to avoid any kind of food except an elemental formula for a four-week period. Three patients abandoned the study protocol on the first day and eight more consumed forbidden solid foods during the first 2 weeks of the study period. A pathological infiltration of 915 eos/hpf persisted in only one out of the 18 adults who completed the study (4, grade C), giving a per-protocol efficacy of 94.4 %, which went down to 58.8 % when analyzed for intention-to treat.
& A rapid recurrence of eosinophilic inflammation after resuming a normal diet is the norm in both children and adults; therefore, additional dietary strategies should be implemented after elemental diet-induced remission of the disease. & Although the efficacy of an elemental diet has proven superior to that of any other type of dietary intervention in managing EoE, several drawbacks restrict its use in clinical practice, including its unpleasant taste (which forces up to 80 % of pediatric patients to be fed through a nasogastric tube [31] ), its high non-adherence rates [48], the many limitations it places on social activities due to the complete avoidance of any kind of table food, and its high cost. This latter limitation leads to the additional disadvantage that some insurance plans do not cover this type of therapy. & The only realistic utility of elemental diet in clinical practice is to feed infants and toddlers, among whom the restriction of having no additional food may be better tolerated, and only during the length of time required for food reintroduction with the goal of identifying specific dietary triggers.
Elimination diets directed by allergy testing
& The growing body of evidence showing that exposure to food allergens leads to EoE has prompted researchers to attempt to identify specific food triggers for the disease, sometimes using clinical histories (which is complicated as patients do not usually associate the consumption of certain foods with the appearance of symptoms), but most often using skin prick tests (SPTs) and/or atopy patch tests (APTs [61] and egg [62] oral immunotherapy. Data on long-term food tolerance induction are still scarce [63] ; the possibility of a change in the pattern of the immune response from Th2 to Th1-type should be taken into account. & As a result, a recent retrospective study [64•] focusing solely on cow's milk showed significant histological remission of EoE (G15 eos/hpf) in 65 % of children and symptom improvement in all patients after the elimination of milk from the diet. The unexpectedly high efficacy of this strategy may have been influenced in this study by the inclusion of patients with a particular allergic background, i.e., a previous IgE-mediated cow's milk allergy undergoing desensitization. & In conclusion, EoE patients with a previous history of Th2-mediated food allergy and who are undergoing oral desensitization should be considered for specific single-food removal, followed by endoscopic and bioptic monitoring for EoE remission. The advantages and drawbacks of re-exposing the patient to allergic reaction, including anaphylaxis in the case of accidental consumption, should be carefully weighed.
Food reintroduction and identification of food triggers
& Food reintroduction is essential in the dietary management of EoE and should always be considered after patients on elemental or elimination diets present normal esophageal biopsies. Food reintroduction has the double aim of selectively identifying foods that trigger EoE, as well as improving patient acceptance of and adherence to a less restrictive diet.
& It is worth noting that one or more independent foods can be responsible for EoE; thus, while three out of four Northwestern American (pediatric and adult) patients exhibited a single food trigger [57••, 59 ••], this was documented in only one out of three adult Spanish patients [58••] . Although very limited information is available on this topic, following a more varied diet (the Mediterranean diet as compared to the Northwestern American diet or an adult's diet compared to a child's), may increase the probability of developing a food allergy manifested as EoE. & There are two possible strategies for planning the reintroduction sequence. The first is to begin with foods unlikely to cause EoE (e.g., vegetables and fruits, chicken and beef), in order to normalize the patient's diet as soon as possible [65] . The alternative strategy, assessed in SFED-based trials, consists of first reintroducing wheat and milk, because although they are the most common EoE triggers, if the result is negative, their impact in returning patients to a normal diet is higher [58••] . & After demonstrating EoE triggered by cow's milk, the immediate reintroduction of soy may provide patents with an effective milk-substitute. Due to the common cross-reactivity with cow's milk proteins, sheep's and goat's milk-derived products (mainly cheeses) should also be excluded.
How can we succeed in the dietary management of EoE patients?
& The lack of multicenter, randomized, comparative studies on the effectiveness, advantages and drawbacks of empirical elimination diets vs. skin allergy testing prevent us from undoubtedly recommending one dietary option over another. However, available evidences show that SFED seems to be the best current dietary approach for treating EoE patients, having provided the greater and more consistent results in different studies, and it should be considered for both children and motivated adults. Until better and more accurate food allergy testing capable of identifying specific food triggers is available or until genetic profiling can accurately predict individual responses to diet, the unreliability of skin allergy testing limits the use of this method to experienced centers where it has been proven to be efficient. & Food triggers of EoE have repeatedly been demonstrated to be foods commonly consumed in the standard Western diet, including milk, wheat, and eggs. This begs the question of whether these trigger foods are the same for other geographical regions, for example, Asia, where rice and soy are common in the staple diet. Consequently, when planning a dietary intervention to manage EoE, it should be taken into account that allergy sensitization patterns depend on antigen exposure, which varies from one place to another [66] [67] [68] .
& As a result, it seems reasonable to design food interventions based on skin allergy testing or empirical elimination according to the staple diet, adapting each strategy to regional consumption habits and allergy sensitization patterns. [71] . However, a novel, minimally invasive string test was recently found to accurately reflect mucosal eosinophilic inflammation by measuring eosinophil-derived proteins in luminal secretions [72] . Further research is needed to demonstrate the usefulness of this test in clinical practice. & Finally, in order to better define novel and targeted dietary-based therapies, the many unresolved aspects concerning the immunological and physiopathological mechanisms of EoE must be elucidated.
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